Jennifer Laframboise
Nurse Practitioner · Grand Forks, NDNPI 1336494574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 50.8% of the total. Reporting peaked in 2023 at $659 and has fallen 76.6% since, to $154 in 2025.
Across 66 payments — averaging $25.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- Galderma Laboratories, L.p.$280
- LEO Pharma Inc.$132
- Lilly USA, LLC$125
- Sun Pharmaceutical Industries Inc.$99
- Johnson & Johnson$78
- plus $114 from 4 others
What the payments were for
- Food & beverage$1,57994%
- Education$1026%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $854 |
| Galderma Laboratories, L.p. | 8 | $280 |
| LEO Pharma Inc. | 2 | $132 |
| Lilly USA, LLC | 7 | $125 |
| Sun Pharmaceutical Industries Inc. | 2 | $99 |
| Johnson & Johnson | 1 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| UCB, Inc. | 1 | $22 |
| Sanofi | 1 | $15 |
| Incyte Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$107
How this compares
$1,681 in reported general payments places this provider in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 16 | $63,905 |
| Dupixent PenDupilumab | 19 | $37,838 |
| MethotrexateMethotrexate Sodium | 85 | $3,502 |
| Clobetasol Propionate | 65 | $3,228 |
| Triamcinolone Acetonide | 112 | $1,814 |
| Imiquimod | 32 | $1,487 |
| Betamethasone Dipropionate | 32 | $1,437 |
| Metronidazole | 26 | $1,214 |
| Ketoconazole | 35 | $489 |
| ValacyclovirValacyclovir Hcl | 17 | $485 |
| Doxycycline Hyclate | 25 | $477 |
| Mometasone Furoate | 24 | $412 |
| Prednisone | 62 | $306 |
| Cephalexin | 49 | $260 |
| Ondansetron Hcl | 39 | $208 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Grand Forks
- Nicole MorganGrand Forks$7K
- Marlie BorowiczGrand Forks$5K
- Caroline SchroederGrand Forks$3K
- Wade OlsonGrand Forks$3K
- Melissa HayesGrand Forks$1K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- Jenna KelschMinot$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.